Total Payments
$4,079
2024 Payments
$2,003
Companies
7
Transactions
28
Medicare Patients
325
Medicare Billing
$32,726
Payment Breakdown by Category
Food & Beverage$2,200 (53.9%)
Consulting$1,521 (37.3%)
Travel$358.26 (8.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,200 | 24 | 53.9% |
| Consulting Fee | $1,521 | 3 | 37.3% |
| Travel and Lodging | $358.26 | 1 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,158 | 10 | $0 (2024) |
| ABBVIE INC. | $689.81 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $489.30 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $335.30 | 2 | $0 (2023) |
| Celgene Corporation | $268.08 | 2 | $0 (2024) |
| GENZYME CORPORATION | $88.81 | 1 | $0 (2024) |
| PFIZER INC. | $49.82 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,003 | 13 | Janssen Biotech, Inc. ($1,274) |
| 2023 | $2,005 | 14 | Janssen Biotech, Inc. ($883.35) |
| 2021 | $71.50 | 1 | AbbVie Inc. ($71.50) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $125.17 | General |
| 12/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $58.50 | General |
| Category: Immunology | ||||||
| 12/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.08 | General |
| Category: Immunology | ||||||
| 09/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Immunology | ||||||
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $88.81 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $36.62 | General |
| Category: Immunology | ||||||
| 07/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $120.65 | General |
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $146.96 | General |
| Category: Immunology | ||||||
| 05/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.02 | General |
| 04/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $122.35 | General |
| Category: Neuroscience | ||||||
| 04/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $147.45 | General |
| 04/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.48 | General |
| Category: Immunology | ||||||
| 12/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $145.73 | General |
| Category: Neuroscience | ||||||
| 12/06/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY, VELSIPITY | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY, VELSIPITY | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/08/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY, VELSIPITY | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/19/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $137.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Travel and Lodging | Cash or cash equivalent | $358.26 | General |
| Category: Immunology | ||||||
| 09/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Consulting Fee | Cash or cash equivalent | $271.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Immunology | ||||||
| 09/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $64.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/19/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $126.14 | General |
| 04/25/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $125.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 75 | 102 | $36,432 | $7,556 |
| 2022 | 2 | 45 | 58 | $21,233 | $4,296 |
| 2020 | 5 | 205 | 270 | $116,187 | $20,874 |
Total Patients
325
Total Services
430
Medicare Billing
$32,726
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 58 | $18,908 | $3,953 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 30 | $14,430 | $2,937 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $3,094 | $665.56 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 43 | $14,018 | $2,800 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 15 | $7,215 | $1,496 | 20.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 104 | $46,645 | $8,197 | 17.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 59 | 84 | $37,662 | $6,901 | 18.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 23 | $13,755 | $2,410 | 17.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 37 | $11,365 | $2,131 | 18.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 22 | $6,760 | $1,234 | 18.3% |
About Alison Krustapentus, FNP
Alison Krustapentus, FNP is a Family healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1497272413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alison Krustapentus, FNP has received a total of $4,079 in payments from pharmaceutical and medical device companies, with $2,003 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($2,200).
As a Medicare-enrolled provider, Krustapentus has provided services to 325 Medicare beneficiaries, totaling 430 services with total Medicare billing of $32,726. Data is available for 3 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Boston, MA
- Active Since 08/30/2017
- Last Updated 08/30/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1497272413
Products in Payments
- TREMFYA (Drug) $1,238
- STELARA (Biological) $919.97
- ENTYVIO (Biological) $335.30
- ZEPOSIA (Drug) $268.08
- SKYRIZI (Biological) $258.45
- RINVOQ (Biological) $110.67
- DUPIXENT (Biological) $88.81
- HUMIRA (Biological) $71.50
- XELJANZ (Drug) $49.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Boston
Brittany Murray, Msn, Aprn, Fnp-Bc, MSN, APRN, FNP-BC
Family — Payments: $91,393
Family $91,393
Ms. Naomi Amudala, Np, NP
Family — Payments: $40,295
Family $40,295
Mrs. Alexa Costa, Np-C, NP-C
Family — Payments: $16,778
Family $16,778
Caitlin Murphy, Dnp, DNP
Family — Payments: $15,757
Family $15,757
Lauren Camillieri, Fnp-Bc, FNP-BC
Family — Payments: $7,681
Family $7,681
Charlene Sylvestre, N.p, N.P
Family — Payments: $6,498
Family $6,498